FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200126402> ?p ?o ?g. }

• W4200126402 endingPage "49" @default.
• W4200126402 startingPage "34" @default.
• W4200126402 abstract "Hepatocellular carcinoma (HCC) is disease with a high mortality rate and limited treatment options. Alterations of fibroblast growth factor receptor 4 (FGFR4) has been regarded as an oncogenic driver for HCC and a promising target for HCC therapeutics. Herein, we report that GNF-7, a multi-targeted kinase inhibitor, and its derivatives including SIJ1263 (IC50 < 1 nM against FGFR4) are highly potent FGFR4 inhibitors and are capable of strongly suppressing proliferation of HCC cells and Ba/F3 cells transformed with wtFGFR4 or mtFGFR4. Compared with known FGFR4 inhibitors, both GNF-7 and SIJ1263 possess much higher (up to 100-fold) anti-proliferative activities via FGFR signaling blockade and apoptosis on HCC cells. Especially, SIJ1263 is 80-fold more potent (GI50 = 24 nM) on TEL-FGFR4 V550E Ba/F3 cells than BLU9931, which suggests that SIJ1263 would be effective for overriding drug resistance. In addition, both substances strongly suppress migration/invasion and colony formation of HCC cells. It is worth noting that SIJ1263 is superior to GNF-7 with regards to the fact that activities of SIJ1263 are higher than those of GNF-7 in all assays performed in this study. Collectively, this study provides insight into designing highly potent FGFR4 inhibitors capable of potentially overcoming drug-resistance for the treatment of HCC patients." @default.
• W4200126402 created "2021-12-31" @default.
• W4200126402 creator A5004615703 @default.
• W4200126402 creator A5006659812 @default.
• W4200126402 creator A5008073134 @default.
• W4200126402 creator A5028980108 @default.
• W4200126402 creator A5051982385 @default.
• W4200126402 creator A5072980780 @default.
• W4200126402 creator A5088690302 @default.
• W4200126402 date "2022-01-01" @default.
• W4200126402 modified "2023-09-26" @default.
• W4200126402 title "Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation" @default.
• W4200126402 cites W1863396492 @default.
• W4200126402 cites W1963822859 @default.
• W4200126402 cites W1971837077 @default.
• W4200126402 cites W2002877827 @default.
• W4200126402 cites W2004576498 @default.
• W4200126402 cites W2005156121 @default.
• W4200126402 cites W2054233869 @default.
• W4200126402 cites W2076785980 @default.
• W4200126402 cites W2078058991 @default.
• W4200126402 cites W2093090488 @default.
• W4200126402 cites W2101431311 @default.
• W4200126402 cites W2107959852 @default.
• W4200126402 cites W2112817429 @default.
• W4200126402 cites W2118952669 @default.
• W4200126402 cites W2130787560 @default.
• W4200126402 cites W2154758108 @default.
• W4200126402 cites W2209465445 @default.
• W4200126402 cites W2263171370 @default.
• W4200126402 cites W2399578646 @default.
• W4200126402 cites W2495013142 @default.
• W4200126402 cites W2529646902 @default.
• W4200126402 cites W2560499218 @default.
• W4200126402 cites W2570752112 @default.
• W4200126402 cites W2606367731 @default.
• W4200126402 cites W2761457458 @default.
• W4200126402 cites W2773998260 @default.
• W4200126402 cites W2787358630 @default.
• W4200126402 cites W2793412163 @default.
• W4200126402 cites W2809889937 @default.
• W4200126402 cites W2889396449 @default.
• W4200126402 cites W2889646458 @default.
• W4200126402 cites W2898314774 @default.
• W4200126402 cites W2900051936 @default.
• W4200126402 cites W2908573150 @default.
• W4200126402 cites W2909259623 @default.
• W4200126402 cites W2912201468 @default.
• W4200126402 cites W2968913253 @default.
• W4200126402 cites W2977600124 @default.
• W4200126402 cites W2978029751 @default.
• W4200126402 cites W3009349681 @default.
• W4200126402 cites W3082678448 @default.
• W4200126402 cites W3087582521 @default.
• W4200126402 cites W3092600130 @default.
• W4200126402 cites W3133722275 @default.
• W4200126402 cites W3136550777 @default.
• W4200126402 doi "https://doi.org/10.1016/j.neo.2021.11.011" @default.
• W4200126402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34864570" @default.
• W4200126402 hasPublicationYear "2022" @default.
• W4200126402 type Work @default.
• W4200126402 citedByCount "0" @default.
• W4200126402 crossrefType "journal-article" @default.
• W4200126402 hasAuthorship W4200126402A5004615703 @default.
• W4200126402 hasAuthorship W4200126402A5006659812 @default.
• W4200126402 hasAuthorship W4200126402A5008073134 @default.
• W4200126402 hasAuthorship W4200126402A5028980108 @default.
• W4200126402 hasAuthorship W4200126402A5051982385 @default.
• W4200126402 hasAuthorship W4200126402A5072980780 @default.
• W4200126402 hasAuthorship W4200126402A5088690302 @default.
• W4200126402 hasBestOaLocation W42001264021 @default.
• W4200126402 hasConcept C121608353 @default.
• W4200126402 hasConcept C126322002 @default.
• W4200126402 hasConcept C170493617 @default.
• W4200126402 hasConcept C185592680 @default.
• W4200126402 hasConcept C190283241 @default.
• W4200126402 hasConcept C202751555 @default.
• W4200126402 hasConcept C2777752497 @default.
• W4200126402 hasConcept C2778019345 @default.
• W4200126402 hasConcept C2778468042 @default.
• W4200126402 hasConcept C502942594 @default.
• W4200126402 hasConcept C55493867 @default.
• W4200126402 hasConcept C66400584 @default.
• W4200126402 hasConcept C71924100 @default.
• W4200126402 hasConcept C74373430 @default.
• W4200126402 hasConcept C82867764 @default.
• W4200126402 hasConcept C86803240 @default.
• W4200126402 hasConcept C96232424 @default.
• W4200126402 hasConcept C98274493 @default.
• W4200126402 hasConceptScore W4200126402C121608353 @default.
• W4200126402 hasConceptScore W4200126402C126322002 @default.
• W4200126402 hasConceptScore W4200126402C170493617 @default.
• W4200126402 hasConceptScore W4200126402C185592680 @default.
• W4200126402 hasConceptScore W4200126402C190283241 @default.
• W4200126402 hasConceptScore W4200126402C202751555 @default.
• W4200126402 hasConceptScore W4200126402C2777752497 @default.
• W4200126402 hasConceptScore W4200126402C2778019345 @default.
• W4200126402 hasConceptScore W4200126402C2778468042 @default.

• next